Evidence map›Paper›PMID 41140392›Full record

ArticleFrontiers in microbiology2025

Emergence of high-risk ST595 and ST640 clones of carbapenem-resistant

Yan Zhang, Tong Cao, Jie Zheng, Lingning Meng, Shuo Gao, Han Shen, Wanqing Zhou, Xiaoli Cao

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Molecular Epidemiology of Carbapenem-ResistantInfection and drug resistance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yan Zhang *Department of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Tong Cao *Department of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Jie ZhengDepartment of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Lingning MengDepartment of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Shuo GaoDepartment of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Han ShenDepartment of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Wanqing ZhouDepartment of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Xiaoli CaoDepartment of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Carbapenem-resistant Methods: A total of 52 CRSM clinical isolates collected during a nosocomial outbreak were subjected to whole-genome sequencing (WGS) for comprehensive analysis of virulence factor (VF) profiles, sequence types (STs), and phylogenetic relationships. Based on genomic clustering, representative isolates were selected for Results: All the CRSM carried Conclusion: This study provides the first integrated genomic and phenotypic characterization of CRSM during a documented hospital outbreak, highlighting ST595 and ST640 as high-risk clones with distinct virulence signatures. The convergence of rapid growth, biofilm capacity, and serum resistance in select isolates underscores their potential role in prolonged colonization and nosocomial spread. These findings emphasize the urgent need for genomic surveillance and targeted infection control strategies to curb the dissemination of emerging CRSM clones.

Indexed as

biofilm formationcarbapenem resistancenosocomial outbreaksequence typingSerratia marcescensserum resistancevirulence factorswhole-genome sequencing

Identifiers

PMID41140392
PMCPMC12546152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.